114 related articles for article (PubMed ID: 10549029)
1. Quantitative analysis of the interstitial myofibroblasts in idiopathic mesangiocapillary glomerulonephritis type I.
Danilewicz M; Antoszczyk L; Wagrowska-Danilewicz M
Pathol Res Pract; 1999; 195(10):663-8. PubMed ID: 10549029
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of the interstitial mast cells in idiopathic mesangiocapillary glomerulonephritis type I.
Danilewicz M; Wagrowska-Danilewicz M
Nefrologia; 2001; 21(3):253-9. PubMed ID: 11471306
[TBL] [Abstract][Full Text] [Related]
3. A quantitative study of the interstitial expression of alpha-smooth muscle actin (alpha-SMA) in idiopathic membranous glomerulonephritis and minimal change disease in adults.
Danilewicz M; Wagrowska-Danilewicz M; Antoszczyk L
Pol J Pathol; 2000; 51(1):37-43. PubMed ID: 10833902
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of the interstitial mast cells in rebiopsied patients with idiopathic mesangial proliferative glomerulonephritis.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 2005; 56(2):63-8. PubMed ID: 16092667
[TBL] [Abstract][Full Text] [Related]
5. A correlation between immunoexpression of CD44, alpha-SMA and CD68+ cells in IgA-nephropathy and in mesangial proliferative IgA-negative glomerulonephritis.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2002; 53(3):155-62. PubMed ID: 12476618
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of interstitial mast cells in lupus and non-lupus membranous glomerulopathy.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 2001; 52(4):211-7. PubMed ID: 11915183
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of interstitial mast cells in AA and AL renal amyloidosis.
Danilewicz M; Wagrowska-Danilewicz M
Pathol Res Pract; 2002; 198(6):413-9. PubMed ID: 12166898
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of the interstitial mast cells in acute rejection of human renal allografts.
Danilewicz M; Wagrowska-Danilewicz M
Med Sci Monit; 2004 May; 10(5):BR151-6. PubMed ID: 15114264
[TBL] [Abstract][Full Text] [Related]
9. Mesangiocapillary glomerulonephritis type III and idiopathic membranous glomerulopathy. Morphometric comparison of the deposits and glomerular basement membrane including clinico-morphological correlations.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 1997; 48(1):43-8. PubMed ID: 9200960
[TBL] [Abstract][Full Text] [Related]
10. Immunoexpression of alpha-SMA and CD68 in native kidney biopsies.
Jercan O; Penescu M; Mălăescu DG
Rom J Morphol Embryol; 2012; 53(4):1037-42. PubMed ID: 23303029
[TBL] [Abstract][Full Text] [Related]
11. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.
Jinde K; Nikolic-Paterson DJ; Huang XR; Sakai H; Kurokawa K; Atkins RC; Lan HY
Am J Kidney Dis; 2001 Oct; 38(4):761-9. PubMed ID: 11576879
[TBL] [Abstract][Full Text] [Related]
12. A morphometric insight into glomerular and interstitial lesions in acutely rejected renal allografts.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 2003; 54(3):171-7. PubMed ID: 14703283
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in lupus SLE-N IV and non-lupus mesangiocapillary glomerulonephritis type I MCGN. I. A comparative study.
Wagrowska-Danilewicz M; Danilewicz M
J Nephrol; 1998; 11(1):44-9. PubMed ID: 9561485
[TBL] [Abstract][Full Text] [Related]
14. Correlative insights into the immunoexpression of transforming growth factor beta-1 in acutely rejected renal allografts.
Danilewicz M; Wagrowska-Danilewicz M
Pathol Res Pract; 2006; 202(1):9-15. PubMed ID: 16343799
[TBL] [Abstract][Full Text] [Related]
15. Myofibroblast phenotypes expression in experimental renal scarring.
Muchaneta-Kubara EC; el Nahas AM
Nephrol Dial Transplant; 1997 May; 12(5):904-15. PubMed ID: 9175042
[TBL] [Abstract][Full Text] [Related]
16. Interstitial myofibroblasts in IgA glomerulonephritis.
Hewitson TD; Becker GJ
Am J Nephrol; 1995; 15(2):111-7. PubMed ID: 7733146
[TBL] [Abstract][Full Text] [Related]
17. Myofibroblasts and the progression of crescentic glomerulonephritis.
Goumenos D; Tsomi K; Iatrou C; Oldroyd S; Sungur A; Papaioannides D; Moustakas G; Ziroyannis P; Mountokalakis T; El Nahas AM
Nephrol Dial Transplant; 1998 Jul; 13(7):1652-61. PubMed ID: 9681707
[TBL] [Abstract][Full Text] [Related]
18. Stem cell factor and crescentic glomerulonephritis.
El Kossi MM; El Nahas AM
Am J Kidney Dis; 2003 Apr; 41(4):785-95. PubMed ID: 12666065
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with primary immune-complex type mesangiocapillary glomerulonephritis (MCGN) in Cape Town South Africa.
Okpechi IG; Dlamini TA; Duffield M; Rayner BL; Moturi G; Swanepoel CR
PLoS One; 2014; 9(11):e113302. PubMed ID: 25411791
[TBL] [Abstract][Full Text] [Related]
20. A quantitative study of mesangial deposits and glomerular monocytes/macrophages in IgA-nephropathy and proliferative mesangial (non-IgA) glomerulonephritis.
Danilewicz M; Wagrowska-Danilewicz M
J Nephrol; 1998; 11(5):255-60. PubMed ID: 9831239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
